Akebia Ther Company Insiders
AKBA Stock | USD 2.06 0.01 0.49% |
Akebia Ther's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Akebia Ther suggests that vertually all insiders are panicking. Akebia Ther employs about 167 people. The company is managed by 20 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 8.35 employees per reported executive.
Steven Burke President Senior Vice President Chief Medical Officer |
Michel Dahan President Senior Vice President and Chief Business Officer |
Akebia Ther's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-02-29 | Nicole R Hadas | Disposed 5974 @ 1.58 | View | ||
2024-02-27 | Nicole R Hadas | Disposed 7411 @ 1.52 | View | ||
2024-02-01 | Steven Keith Burke | Disposed 24311 @ 1.68 | View |
Monitoring Akebia Ther's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Akebia |
Akebia Ther's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Akebia Ther's future performance. Based on our forecasts, it is anticipated that Akebia will maintain a workforce of about 170 employees by December 2024.Akebia Ther Management Team Effectiveness
The company has return on total asset (ROA) of (0.0937) % which means that it has lost $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5345) %, meaning that it created substantial loss on money invested by shareholders. Akebia Ther's management efficiency ratios could be used to measure how well Akebia Ther manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.78, whereas Return On Tangible Assets are forecasted to decline to (0.37). At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 182 M, whereas Other Current Assets are forecasted to decline to about 12.6 M.As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 97.4 M. In addition to that, Net Loss is expected to decline to about (87.5 M)
Akebia Ther Workforce Comparison
Akebia Ther is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 884. Akebia Ther retains roughly 167 in number of employees claiming about 19% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.33. Akebia Ther Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akebia Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akebia Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Akebia Ther insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-06-01 | 7.0 | 14 | 2 | 525,000 | 46,856 |
2024-03-01 | 1.4 | 14 | 10 | 4,452,300 | 203,429 |
2023-09-01 | 2.0 | 2 | 1 | 930,000 | 27,000 |
2023-06-01 | 5.0 | 20 | 4 | 1,625,000 | 285,798 |
2023-03-01 | 0.3684 | 7 | 19 | 2,784,438 | 217,124 |
2022-06-01 | 16.0 | 16 | 1 | 965,600 | 4,567 |
2022-03-01 | 0.6364 | 14 | 22 | 2,463,658 | 167,843 |
2021-09-01 | 1.0 | 1 | 1 | 200,000 | 1,042 |
2021-06-01 | 1.5 | 12 | 8 | 202,800 | 14,981 |
2021-03-01 | 2.1 | 21 | 10 | 1,775,904 | 135,129 |
2020-06-01 | 3.2 | 16 | 5 | 596,800 | 20,127 |
2020-03-01 | 3.5 | 14 | 4 | 1,499,500 | 24,452 |
2019-12-01 | 6.0 | 6 | 1 | 162,800 | 0.00 |
2019-06-01 | 4.0 | 24 | 6 | 1,161,300 | 334,470 |
2018-12-01 | 4.6667 | 28 | 6 | 445,955 | 222,079 |
2018-09-01 | 2.0 | 2 | 1 | 125,000 | 100,000 |
2018-03-01 | 15.0 | 15 | 1 | 708,400 | 1,000.00 |
2017-09-01 | 0.2 | 1 | 5 | 1,034,482 | 13,943 |
2017-06-01 | 3.0 | 9 | 3 | 300,000 | 3,948 |
2017-03-01 | 3.5 | 14 | 4 | 750,500 | 25,419 |
2016-12-01 | 0.3333 | 1 | 3 | 130,000 | 4,938 |
2016-09-01 | 0.3333 | 1 | 3 | 25,000 | 4,939 |
2016-06-01 | 3.5 | 7 | 2 | 87,500 | 2,957 |
2016-03-01 | 0.7273 | 8 | 11 | 365,300 | 324,978 |
2015-06-01 | 2.6 | 13 | 5 | 518,499 | 54,958 |
2015-03-01 | 1.6 | 8 | 5 | 418,499 | 105,420 |
2014-12-01 | 2.75 | 22 | 8 | 163,086 | 72,209 |
2014-03-01 | 0.4286 | 12 | 28 | 6,507,137 | 10,044,989 |
Akebia Ther Notable Stakeholders
An Akebia Ther stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Akebia Ther often face trade-offs trying to please all of them. Akebia Ther's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Akebia Ther's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John MBA | President, CEO | Profile | |
Steven Burke | Senior Vice President Chief Medical Officer | Profile | |
Michel Dahan | Senior Vice President and Chief Business Officer | Profile | |
CGMA CPA | CFO VP | Profile | |
Nicole Hadas | Sr. VP, General Counsel and Secretary | Profile | |
Kristie Bolieau | VP Controller | Profile | |
Nicole JD | Chief VP | Profile | |
Mercedes Carrasco | Director Communications | Profile | |
David Spellman | CFO VP | Profile | |
Tracey Vetterick | Vice Administration | Profile | |
Thierry Bilbault | VP Devel | Profile | |
Erik MBA | Senior Officer | Profile | |
Douglas MBA | Vice Strategy | Profile | |
Nicholas Grund | Senior Officer | Profile | |
Carolyn Rucci | Senior Counsel | Profile | |
Kimberly Garko | Senior Officer | Profile | |
Meredith Bowman | Senior Officer | Profile | |
Steven MD | Senior Officer | Profile | |
Richard Malabre | Chief Officer | Profile | |
Violetta Cotreau | Chief VP | Profile |
About Akebia Ther Management Performance
The success or failure of an entity such as Akebia Ther often depends on how effective the management is. Akebia Ther management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Akebia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Akebia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.35) | (0.37) | |
Return On Capital Employed | (0.33) | (0.34) | |
Return On Assets | (0.21) | (0.23) | |
Return On Equity | 1.70 | 1.78 |
Please note, the presentation of Akebia Ther's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akebia Ther's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akebia Ther's management manipulating its earnings.
Akebia Ther Workforce Analysis
Traditionally, organizations such as Akebia Ther use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Akebia Ther within its industry.Akebia Ther Manpower Efficiency
Return on Akebia Ther Manpower
Revenue Per Employee | 1.2M | |
Revenue Per Executive | 9.7M | |
Net Loss Per Employee | 310.9K | |
Net Loss Per Executive | 2.6M | |
Working Capital Per Employee | 109.5K | |
Working Capital Per Executive | 914K |
Complementary Tools for Akebia Stock analysis
When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |